rombidux 15 mg
merck healthcare kgaa - germania - rivaroxabanum - compr. film. - 15mg - antitrombotice inhibitori directi ai factorului xa
rombidux 20 mg
merck healthcare kgaa - germania - rivaroxabanum - compr. film. - 20mg - antitrombotice inhibitori directi ai factorului xa
enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - imunosupresoare - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.
lenalidomida alkaloid-int 10 mg
synthon hispania s.l. - spania - lenalidomidum - caps. - 10mg - imunosupresoare alte imunosupresoare
lenalidomida alkaloid-int 15 mg
synthon hispania s.l. - spania - lenalidomidum - caps. - 15mg - imunosupresoare alte imunosupresoare
lenalidomida alkaloid-int 25 mg
synthon hispania s.l. - spania - lenalidomidum - caps. - 25mg - imunosupresoare alte imunosupresoare
lenalidomida alkaloid-int 5 mg
synthon hispania s.l. - spania - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare
rivaroxaban g.l. pharma 15 mg
labormed pharma s.a. - romania - rivaroxabanum - compr. film. - 15mg - antitrombotice inhibitori directi ai factorului xa
rivaroxaban g.l. pharma 20 mg
labormed pharma s.a. - romania - rivaroxabanum - compr. film. - 20mg - antitrombotice inhibitori directi ai factorului xa
rivaroxaban teva 10 mg
teva b.v. - olanda - rivaroxabanum - compr. film. - 10mg - antitrombotice inhibitori directi ai factorului xa